13th Jun 2017 18:01
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi  | 
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii  | 
 PURETECH HEALTH PLC  | |||
2 Reason for the notification (please tick the appropriate box or boxes):  | ||||
An acquisition or disposal of voting rights  | Yes  | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached  | No  | |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments  | No  | |||
An event changing the breakdown of voting rights  | No  | |||
Other (please specify):  | No  | |||
 3. Full name of person(s) subject to the notification obligation: iii  | 
 
 Recordati SA Chemical and Pharmaceutical Company  | |||
 4. Full name of shareholder(s) (if different from 3.):iv  | ||||
5. Date of the transaction and date on which the threshold is crossed or reached: v  | 
 12 June 2017  | |||
6. Date on which issuer notified:  | 13 June 2017  | |||
7. Threshold(s) that is/are crossed or reached: vi, vii  | 
 Below 3%  | |||
8. Notified details:  | ||||||||||||||||
A: Voting rights attached to shares viii, ix  | ||||||||||||||||
Class/type of shares 
 if possible using the ISIN CODE  | Situation previous to the triggering transaction  | Resulting situation after the triggering transaction  | ||||||||||||||
Number of Shares  | Number of Voting Rights  | Number of shares  | Number of voting rights  | % of voting rights x  | ||||||||||||
Direct  | Direct xi  | Indirect xii  | Direct  | Indirect  | ||||||||||||
GB00BY2Z0H74  | 9,554,140  | 9,554,140  | 0  | 0  | 0  | 0%  | 0  | |||||||||
B: Qualifying Financial Instruments  | ||||||||||||||||
Resulting situation after the triggering transaction  | ||||||||||||||||
Type of financial instrument  | Expiration date xiii  | Exercise/ Conversion Period xiv  | Number of voting rights that may be acquired if the instrument is exercised/ converted.  | % of voting rights  | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi  | ||||||||||||||||
Resulting situation after the triggering transaction  | ||||||||||||||||
Type of financial instrument  | Exercise price  | Expiration date xvii  | Exercise/ Conversion period xviii  | Number of voting rights instrument refers to  | % of voting rights xix, xx  | |||||||||||
Nominal  | Delta  | |||||||||||||||
Total (A+B+C)  | ||||||||||||||||
Number of voting rights  | Percentage of voting rights  | |||||||||||||||
0  | 0%  | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi  | ||
Proxy Voting:  | ||
10. Name of the proxy holder:  | ||
11. Number of voting rights proxy holder will cease to hold:  | ||
12. Date on which proxy holder will cease to hold voting rights:  | ||
 13. Additional information:  | This transfer of voting rights relates to a merger by absorption of Recordati SA Chemical and Pharmaceutical Company into Recordati S.p.A, with Recordati S.p.A as the surviving entity.  | |
14. Contact name:  | 
 Silvia Signoretti  | |
15. Contact telephone number:  | 
 +39 02 48787533  | |
Related Shares:
PureTech